February 2021. The authors investigated the administration of the growth hormone (GH) in
IVF/PGT-A cycles in women without poor ovarian response (POR) with a suboptimal …

Background: The efficiency of in vitro fertilization is improved by growth hormone (GH)
during ovarian stimulation. Additionally, patients with diabetes experience impaired insulin …

Background hMG and recombinant FSH, have both been used successfully for controlled
ovarian hyperstimulation in in vitro fertilization and embryo transfer (IVF‐ET). Objectives To …

Study question What is the relative effectiveness and safety of existing COS protocols for
women undergoing assisted reproductive technology (ART) treatment? Summary answer …

Objective To systematically review the efficacy of a combination of recombinant follicle‐
stimulating hormone (rFSH) and recombinant luteinizing hormone (rLH) protocol versus …

The objective of this study was to investigate the optimal controlled ovarian hyperstimulation
(COH) protocol for patients aged 35 and above with poor ovarian response (POR), utilizing …

The study aimed to evaluate the impact of the dual trigger with the combination of GnRH
agonist and standard dose of recombinant hCG on IVF outcomes in poor ovarian …

Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

Background To determine whether progestin-primed ovarian stimulation (PPOS) is more
effective for women with diminished ovarian reserve (DOR) than clomiphene citrate …

Background The potential benefit of adding recombinant human luteinizing hormone (r-hLH)
to recombinant human follicle-stimulating hormone (r-hFSH) during ovarian stimulation is a …